| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1099596896 |
| P356 | DOI | 10.1186/S12935-017-0469-8 |
| P8608 | Fatcat ID | release_u3dzdisct5crfiwrl2ovdyctm4 |
| P932 | PMC publication ID | 5721693 |
| P698 | PubMed publication ID | 29234238 |
| P2093 | author name string | Li Li | |
| Gang Chen | |||
| Jun Cao | |||
| Fan Wang | |||
| Dongdong Wang | |||
| Ding Luo | |||
| Xiongqi Zhao | |||
| Jianhua Bai | |||
| Yingpeng Zhao | |||
| P2860 | cites work | MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma | Q36571466 |
| The roles of microRNA in cancer and apoptosis | Q37338421 | ||
| The complexities of microRNA regulation: mirandering around the rules | Q37607457 | ||
| Wnt signalling and the control of cellular metabolism. | Q37708317 | ||
| Emerging targeted strategies in advanced hepatocellular carcinoma | Q38086183 | ||
| The multiple roles of microRNA-155 in oncogenesis | Q38145349 | ||
| Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis | Q38146339 | ||
| Molecular targeted therapy for hepatocellular carcinoma: current and future | Q38151670 | ||
| New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions | Q38282800 | ||
| Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma | Q38489886 | ||
| Regulation of the oncogenic function of distal-less 4 by microRNA-122 in hepatocellular carcinoma | Q38893133 | ||
| microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies. | Q39201324 | ||
| Akt participation in the Wnt signaling pathway through Dishevelled | Q40817549 | ||
| MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4. | Q40962436 | ||
| Molecular mechanism of hepatocarcinogenesis | Q41667327 | ||
| MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK. | Q41858628 | ||
| [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis] | Q81831557 | ||
| [Progress of epigenetics and its therapeutic application in hepatocellular carcinoma] | Q86093458 | ||
| Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition | Q24305416 | ||
| MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases | Q26750448 | ||
| Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy | Q27005850 | ||
| Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis | Q27310338 | ||
| Multidimensional Roles of Collagen Triple Helix Repeat Containing 1 (CTHRC1) in Malignant Cancers | Q28075715 | ||
| MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma | Q28077754 | ||
| The widespread regulation of microRNA biogenesis, function and decay | Q28131796 | ||
| Proliferation, cell cycle and apoptosis in cancer | Q28189476 | ||
| Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors | Q28247928 | ||
| Posttranscriptional regulation of microRNA biogenesis in animals | Q28282519 | ||
| Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility | Q33882067 | ||
| Targeting microRNAs in cancer: rationale, strategies and challenges | Q34141089 | ||
| Mechanisms of control of microRNA biogenesis. | Q34310633 | ||
| Hepatocellular carcinoma: an update | Q34488704 | ||
| Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers | Q34538752 | ||
| Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer | Q34619383 | ||
| Mechanisms of Human Hepatocarcinogenesis | Q35550467 | ||
| The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect | Q35877405 | ||
| MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1. | Q35925686 | ||
| miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4. | Q36283304 | ||
| High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis | Q36546475 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 118 | |
| P577 | publication date | 2017-12-08 | |
| P1433 | published in | Cancer Cell International | Q1829859 |
| P1476 | title | miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling | |
| P478 | volume | 17 |
| Q90427370 | CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma |
| Q90216342 | CTHRC1 and PD‑1/PD‑L1 expression predicts tumor recurrence in prostate cancer |
| Q90479123 | GSK3β inhibits epithelial-mesenchymal transition via the Wnt/β-catenin and PI3K/Akt pathways |
| Q61807260 | Identification of prognostic biomarkers for patients with hepatocellular carcinoma after hepatectomy |
| Q58747357 | Inactivation of Stat3 and crosstalk of miRNA155-5p and FOXO3a contribute to the induction of IGFBP1 expression by beta-elemene in human lung cancer |
| Q91856378 | Interplay between CTHRC1 and the SU protein of avian leukosis virus subgroup J (ALV-J) facilitates viral replication |
| Q101564547 | Let-7c-5p Inhibits Cell Proliferation and Migration and Promotes Apoptosis via the CTHRC1/AKT/ERK Pathway in Esophageal Squamous Cell Carcinoma |
| Q64082096 | MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1 |
| Q58797486 | XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p |
Search more.